Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ekso Bionics Holdings (EKSO) Equity Ratio (2016 - 2026)

Ekso Bionics Holdings has reported Equity Ratio over the past 14 years, most recently at 0.45 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 5.86% to 0.45 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.45, a 5.86% decrease, with the full-year FY2025 number at 0.45, down 5.86% from a year prior.
  • Equity Ratio reached 0.45 in Q4 2025 per EKSO's latest filing, roughly flat from 0.45 in the prior quarter.
  • The five-year high for Equity Ratio was 0.78 in Q2 2022, with the low at 0.44 in Q4 2023.
  • The 5-year median for Equity Ratio is 0.52 (2023), against an average of 0.58.
  • Peak YoY movement for Equity Ratio: skyrocketed 251.65% in 2021, then crashed 33.09% in 2023.
  • Tracing EKSO's Equity Ratio over 5 years: stood at 0.76 in 2021, then fell by 17.83% to 0.62 in 2022, then fell by 29.92% to 0.44 in 2023, then grew by 9.37% to 0.48 in 2024, then decreased by 5.86% to 0.45 in 2025.
  • According to Business Quant data, Equity Ratio over the past three periods came in at 0.45, 0.45, and 0.47 for Q4 2025, Q3 2025, and Q2 2025 respectively.